I agree that there is a new feel for the company now. The
I agree that there is a new feel for the company now. The point is SCRC now has cash simply a guess probably 1.8m to 2m after this quarter. Plus we also have the L.O.C. for 4m. When you have close to 6m to do things it changes the whole dynamic.
There is a clown saying how he wants to see if PIMD will be profitable for q4 2014 as we all know we just did 137k for month of January and nothing before that. COMMON SENSE WILL TELL YOU Q4 2014 WILL NOT HAPPEN. ITS PART OF THE SENSATIONALISM OF TALKING IN THE STOCK. HE IS FAILING MISERABLY. NOW HE WILOL START WITH THIS 7M SHARES PRICED TO SELL. AS PIPE STATES ZERO FEAR ZERO CONCERN. I AM INTERESTED TO LEARN THE OTHER AREAS WE ARE GETTING INVOLVED IN.
The company is terrific shape for a BB IN FACT THE BEST OF ANY BB STOCK I KNOW OF. BTW I heard all this noise how PXYN at .065 to start the year would be this and that. I am looking at the tape it says its been betwen .03 and .04.The real deal is scrc and I am proud to be a affliated with all you guys of the
core."
ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Wells Fargo's Recent Adjustments on American Tower Corporation In a recent move, Wells Fargo has made notable adjustments regarding American Tower Corporation (NYSE: AMT). The financial institution has downgraded the company’s stock from Overweight to Equal Weight while also reducing its price target to $230, down from $245. This decision stems from certain...
Continue Reading
WeightWatchers Strengthens Leadership and Expands Health Initiatives WeightWatchers is making headlines as it completes a significant financial reorganization, enhancing its operational capabilities and leadership. With the appointment of respected figures in the health industry, including Dr. Kim Boyd as Chief Medical Officer, the Company aims to expand its services and...
Continue Reading
Unpacking the Short Interest for FactSet Research Systems FactSet Research Systems's short percent of float has seen a decline of 7.56% since its last report, reflecting a changing sentiment among traders. The recent data indicates that the company currently has 2.16 million shares sold short, equating to 6.48% of all its regular shares available for trading. Looking at...
Continue Reading
Investor Insights: Bausch + Lomb Faces Scrutiny Over Stock Drop Bausch + Lomb Corporation, known for its high-quality vision and eye health products, has recently come under fire as Pomerantz LLP initiates a probe on behalf of its investors. This legal investigation stems from potential securities fraud or other irregularities that may affect the company’s integrity and...
Continue Reading
EquipmentShare Faces Legal Storm Alright folks, plenty of us have been around the block long enough to know that when a new IPO gets hitched up to a lawsuit train, you better sit up and take notice. EquipmentShare.com, Inc. (NASDAQ:EQPT), a name that not too long ago was supposed to be a hotshot player in the cloud-based equipment rental game, is knee-deep in legal muck...
Continue Reading